A New Potential Treatment for Postprandial Hypoglycemia Following Bariatric Surgery

Affiliations

Editorial

Sophia M Rössner et al. J Clin Endocrinol Metab. 2021.

. 2021 Jul 13;106(8):e3264-e3265.

doi: 10.1210/clinem/dgab264.

¹ Department of Medicine (H7), Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.

No abstract available

Keywords: GLP-1 antagonist; PBH; avexitide; exendin (9-39); hyperinsulinemic hypoglycemia; postbariatric hypoglycemia.

Comment on

PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia.
Craig CM, Lawler HM, Lee CJE, Tan M, Davis DB, Tong J, Glodowski M, Rogowitz E, Karaman R, McLaughlin TL, Porter L. Craig CM, et al. J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3235-e3248. doi: 10.1210/clinem/dgab103. J Clin Endocrinol Metab. 2021. PMID: 33616643 Free PMC article. Clinical Trial.